APLT Investor Alert Kessler Topaz Meltzer Check, LLP Urges APLT Investors with Losses to ...
| APLT Stock | USD 0.65 0.03 4.84% |
Slightly above 51% of Applied Therapeutics' private investors are presently thinking to get in. The analysis of the overall investor sentiment regarding Applied Therapeutics suggests that some traders are interested. Applied Therapeutics' investing sentiment can be driven by a variety of factors including economic data, Applied Therapeutics' earnings reports, geopolitical events, and overall market trends.
Applied |
RADNOR, Pa., Jan. 03, 2025 -- The law firm of Kessler Topaz Meltzer Check, LLP informs investors that a securities class act
Read at gurufocus.com
 |
Applied Therapeutics Fundamental Analysis
We analyze Applied Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Applied Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Applied Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Sales
Price To Sales Comparative Analysis
Applied Therapeutics is currently under evaluation in price to sales category among its peers. Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Applied Therapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Applied Therapeutics stock to make a market-neutral strategy. Peer analysis of Applied Therapeutics could also be used in its relative valuation, which is a method of valuing Applied Therapeutics by comparing valuation metrics with similar companies.
Peers
Applied Therapeutics Related Equities
| XFOR | X4 Pharmaceuticals | 10.87 | ||||
| VINC | Vincerx Pharma | 7.14 | ||||
| ACRV | Acrivon Therapeutics, | 4.14 | ||||
| LTRN | Lantern Pharma | 2.50 | ||||
| BCAB | Bioatla | 2.08 | ||||
| CCCC | C4 Therapeutics | 2.07 | ||||
| STTK | Shattuck Labs | 1.83 | ||||
| CGEM | Cullinan Oncology | 1.18 | ||||
| DAWN | Day One | 1.13 | ||||
| HOOK | Hookipa Pharma | 0.52 | ||||
| SEER | Seer | 0.87 | ||||
| PMVP | Pmv Pharmaceuticals | 1.44 | ||||
| TERN | Terns Pharmaceuticals | 1.56 | ||||
| ANEB | Anebulo Pharmaceuticals | 1.85 | ||||
| MLYS | Mineralys Therapeutics, | 2.74 | ||||
| GANX | Gain Therapeutics | 3.80 | ||||
| MOLN | Molecular Partners | 4.30 | ||||
| ORIC | Oric Pharmaceuticals | 4.58 | ||||
| LYRA | Lyra Therapeutics | 5.00 | ||||
| INAB | In8bio | 6.25 |
Additional Tools for Applied Stock Analysis
When running Applied Therapeutics' price analysis, check to measure Applied Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Applied Therapeutics is operating at the current time. Most of Applied Therapeutics' value examination focuses on studying past and present price action to predict the probability of Applied Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Applied Therapeutics' price. Additionally, you may evaluate how the addition of Applied Therapeutics to your portfolios can decrease your overall portfolio volatility.